ArticleThe Lancet. Digital health2022
Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data.
Article in The Lancet. Digital health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Improving Fairness and Mitigating Bias in Multicenter Electronic Health Records Models to Predict Glaucoma Outcomes.Ophthalmology science · 2026Article
- Threading the Needle: Practical Considerations for Merging Theory-Driven Computational Psychiatry With Data-Driven Analytics to Enhance Precision Health at Scale.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026Review
- Artificial Intelligence to Guide Repurposing of Drugs.Annual review of medicine · 2026Review
- Predicting intracranial pressure monitor placement in children with traumatic brain injury: a prospective cohort study to develop a clinical decision support tool.Journal of the American Medical Informatics Association : JAMIA · 2026Observational
- From static snapshots to longitudinal trajectories: artificial intelligence in women's reproductive and ovarian health.Frontiers in endocrinology · 2026Review
- Opportunities for AI-based Model-informed Drug Development: A Comparative Analysis of NONMEM and AI-based Models for Population Pharmacokinetic Prediction.The AAPS journal · 2025Article
- Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI Models.JAMA network open · 2025Article
- Multimodal machine learning to predict surgical site infection with healthcare workload impact assessment.NPJ digital medicine · 2025Article
- Predicting appropriateness of antibiotic treatment among ICU patients with hospital-acquired infection.NPJ digital medicine · 2025Article
- Use of machine learning models to predict mechanical ventilation, ECMO, and mortality in COVID-19.Frontiers in artificial intelligence · 2025Article
- Predicting Severe Respiratory Failure in Patients with COVID-19: A Machine Learning Approach.Journal of clinical medicine · 2024Article
- A tri-light warning system for hospitalized COVID-19 patients: Credibility-based risk stratification for future pandemic preparedness.European journal of radiology open · 2024Article
- GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.PLoS computational biology · 2024Article
- An open-source framework for end-to-end analysis of electronic health record data.Nature medicine · 2024Article
- Deep learning-based prediction of one-year mortality in Finland is an accurate but unfair aging marker.Nature aging · 2024Article
- An interpretable predictive deep learning platform for pediatric metabolic diseases.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Deep learning model for personalized prediction of positive MRSA culture using time-series electronic health records.Nature communications · 2024Article
- Dynamic Prognosis Prediction for Patients on DAPT After Drug-Eluting Stent Implantation: Model Development and Validation.Journal of the American Heart Association · 2024Article
- In-hospital real-time prediction of COVID-19 severity regardless of disease phase using electronic health records.PloS one · 2024Article
- One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2.Journal of medical virology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPredicting outcomes of patients with COVID-19 at an early stage is crucial for optimised clinical care and resource management, especially during a pandemic. Although multiple machine learning models have been proposed to address this issue, because of their requirements for extensive data preprocessing and feature engineering, they have not been validated or implemented outside of their original study site. Therefore, we aimed to develop accurate and transferrable predictive models of outcomes on hospital admission for patients with COVID-19.
methodsIn this study, we developed recurrent neural network-based models (CovRNN) to predict the outcomes of patients with COVID-19 by use of available electronic health record data on admission to hospital, without the need for specific feature selection or missing data imputation. CovRNN was designed to predict three outcomes: in-hospital mortality, need for mechanical ventilation, and prolonged hospital stay (>7 days). For in-hospital mortality and mechanical ventilation, CovRNN produced time-to-event risk scores (survival prediction; evaluated by the concordance index) and all-time risk scores (binary prediction; area under the receiver operating characteristic curve [AUROC] was the main metric); we only trained a binary classification model for prolonged hospital stay. For binary classification tasks, we compared CovRNN against traditional machine learning algorithms: logistic regression and light gradient boost machine. Our models were trained and validated on the heterogeneous, deidentified data of 247 960 patients with COVID-19 from 87 US health-care systems derived from the Cerner Real-World COVID-19 Q3 Dataset up to September 2020. We held out the data of 4175 patients from two hospitals for external validation. The remaining 243 785 patients from the 85 health systems were grouped into training (n=170 626), validation (n=24 378), and multi-hospital test (n=48 781) sets. Model performance was evaluated in the multi-hospital test set. The transferability of CovRNN was externally validated by use of deidentified data from 36 140 patients derived from the US-based Optum deidentified COVID-19 electronic health record dataset (version 1015; from January, 2007, to Oct 15, 2020). Exact dates of data extraction were masked by the databases to ensure patient data safety.
findingsCovRNN binary models achieved AUROCs of 93·0% (95% CI 92·6-93·4) for the prediction of in-hospital mortality, 92·9% (92·6-93·2) for the prediction of mechanical ventilation, and 86·5% (86·2-86·9) for the prediction of a prolonged hospital stay, outperforming light gradient boost machine and logistic regression algorithms. External validation confirmed AUROCs in similar ranges (91·3-97·0% for in-hospital mortality prediction, 91·5-96·0% for the prediction of mechanical ventilation, and 81·0-88·3% for the prediction of prolonged hospital stay). For survival prediction, CovRNN achieved a concordance index of 86·0% (95% CI 85·1-86·9) for in-hospital mortality and 92·6% (92·2-93·0) for mechanical ventilation.
interpretationTrained on a large, heterogeneous, real-world dataset, our CovRNN models showed high prediction accuracy and transferability through consistently good performances on multiple external datasets. Our results show the feasibility of a COVID-19 predictive model that delivers high accuracy without the need for complex feature engineering.
fundingCancer Prevention and Research Institute of Texas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.